Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2025) 110 EP507 | DOI: 10.1530/endoabs.110.EP507

ECEESPE2025 ePoster Presentations Diabetes and Insulin (245 abstracts)

Blood lipid profile of patients with diabetes mellitus of various degrees of severity

Gulnora Artykbaeva 1 & Talat Saatov 1


1Institute of biophysics and biochemistry under Mirzo Ulugbek National University of Uzbekistan, lab of metabolomics, Tashkent, Uzbekistan


JOINT2360

Diabetes mellitus (DM) is characterized by a global metabolic disorder, not only of carbohydrate but also lipid metabolism. Consumption of high-calorie diets and lack of physical activity in the long term lead to the accumulation of very low-density lipoprotein cholesterol (VLDL-C), which accelerates the development of atherosclerosis and is a major risk factor for cardiovascular diseases. The purpose of the work was to study the indicators of lipid metabolism in the blood of patients with diabetes of varying severity. The mild form is characterized by a glucose level of up to 8 mmol/l on an empty stomach, the moderate form is up to 14 mmol/l, the severe form of diabetes is over 14 mmol/l. Indicators of total blood lipids in the control were 5.20±0.33 g/l and significantly increased at all degrees of severity (P<0.05). Total cholesterol in the control was 4.89±0.10 mmol/l; in diabetes it significantly increased to 6.0±0.17 in mild form, to 5.95±0.11 in moderate form, to 5.79± 0.16 mmol/l (P<0.05) in severe cases. The level of triglycerides in the control was 1.56±0.21 mmol/l, with mild diabetes it was significantly increased to 1.84±0.05, with moderate severity - 2.25±0.04, with severe diabetes - 2.98±0.34 mmol/l (P<0.05). VLDL and LDL cholesterol in the control corresponded to 10.47±1.24 mmol/l. In the mild form, this indicator was increased to 26.36±3.51 (P<0.01), in the moderate form – to 26.41±2.04, in the severe form – to 15.35±0.31 mmol/l. At the same time, HDL cholesterol significantly decreased in all groups. The lipid spectrum of patients with diabetes shows a significant increase in atherogenic lipoproteins and a decrease in antiatherogenic lipoproteins.

Volume 110

Joint Congress of the European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) 2025: Connecting Endocrinology Across the Life Course

European Society of Endocrinology 
European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches